Radiotherapy plus chemotherapy in muscle-invasive bladder cancer

New England Journal of Medicine

Volumn 367, Issue 4, 2012, Pages 380-

  Atkins, Carl D ^a   Wrzesinski, Stephen H ^a  

^a St Peter's Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BLADDER CANCER; CANCER LOCALIZATION; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; HUMAN; LETTER; MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

EID: 84864210457     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1206002     Document Type: Letter

References (4)

1. Shipley WU, Zietman AL. Old drugs, new purpose - bladder cancer turns a corner. N Engl J Med 2012;366:1540-1.
2. Inference on proportions. In: Colton T. Statistics in medicine. Boston: Little, Brown, 1974:151-88.
3. Rothman KJ. A show of confidence. N Engl J Med 1978;299:1362-3.
4. Freiman JA, Chalmers TC, Smith H Jr, Keubler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized clinical trial: survey of 71 representative trials. N Engl J Med 1978;299:690-4. (Pubitemid 9053296)